tiprankstipranks
Trending News
More News >

Anteris Technologies Unveils Positive DurAVR® Patient Outcomes

Story Highlights
  • Anteris announced positive one-year outcomes for its DurAVR® THV on March 21, 2025.
  • The results show sustained performance and zero PPM, enhancing DurAVR®’s potential in the TAVR market.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Anteris Technologies Unveils Positive DurAVR® Patient Outcomes

Confident Investing Starts Here:

Anteris Technologies Global Corp. ( (AVR) ) has shared an announcement.

On March 21, 2025, Anteris Technologies Global Corp. announced favorable one-year patient outcomes for its DurAVR® Transcatheter Heart Valve (THV) System. The results, presented at Sydney Valves, highlighted the valve’s sustained hemodynamic performance and zero prosthesis-patient mismatch (PPM) in small annuli patients, a significant achievement compared to current commercial devices. These outcomes reinforce the potential of DurAVR® as a transformative solution in the transcatheter aortic valve replacement (TAVR) market, with implications for improved long-term patient outcomes and plans for a global pivotal study.

More about Anteris Technologies Global Corp.

Anteris Technologies Global Corp. is a global structural heart company focused on designing, developing, and commercializing innovative medical devices to restore healthy heart function. The company, founded in Australia with a significant presence in Minneapolis, USA, is known for its lead product, the DurAVR® Transcatheter Heart Valve (THV), which is designed to treat aortic stenosis using its patented anti-calcification tissue technology.

YTD Price Performance: 11.89%

Average Trading Volume: 129,408

Find detailed analytics on AVR stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App